PIK3CA is under investigation in clinical trial NCT02957266 (Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.